Marc Bozec

Chief Executive Officer @Ose Immunotherapeutics

Paris, FR
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Oct 2025 — Present

Chief Executive Officer @Ose Immunotherapeutics

View department →

Paris, FR

SKILLS

Drug DiscoveryLifesciencesBiotechnologyMolecular Biology

ABOUT MARC BOZEC

I started my first biotech company, BioProtein technologies, back in 1998. We have been instrumental in the approval of a recombinant Factor VII for hemophilia. I further joined Cellectis as a CFO that I made public on Paris Stock Market early 2007. I raised €120m along my CFOship there. I then joined CYTOO as a CEO from 2013 to 2015 and later on I refinanced the company with Jacques Lewiner and Gilles and Paul Amouyal. It is now a growing CRO showcasing a unique cell-based assay technology.I had a second life as a professional investor at Financière Arbevel (20••••23) where I raised two funds (UCITS and Private Equity) in Life Sciences. I really appreciated this job and will come back to it for sure in the coming years when the market will re-open.I have been an advisor for series of companies since I left Arbevel mid-2023 and I joined Nicox BoD mid-2024.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Marc Bozec — Chief Executive Officer at Ose Immunotherapeutics in Paris, FR | Unifers